TipRanks
Go Ultimate55% OFF

Vaccinex (VCNX) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Avelumab And PepinemabMetastatic Pancreatic Adenocarcinomaphase1AndPhase2Active Not RecruitingTrial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic AdenocarcinomaOct 21, 2021―
Pepinemab + PembrolizumabRecurrent/Metastatic Squamous Cell Carcinoma Of The Head And Neck (Hnscc)phase1AndPhase2CompletedPepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckMar 22, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vaccinex (VCNX) have in its pipeline
Vaccinex VCNX is currently developing the following drugs: Avelumab And Pepinemab, Pepinemab + Pembrolizumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.